The RECORD Asia-Pacific Atrial Fibrillation Registry (RECORDAF-AP)

Sanofi

Status: Completed

Conditions: Atrial Fibrillation

Study type: Observational

Funder types: Industry

Identifiers

NCT00995748

DIREG_R_04434

Details and patient eligibility

About

The Primary objective of this registry is to assess the control of Atrial Fibrillation (AF) over one year in patients attending clinical or specialized practices.

The Secondary objectives are:

• To describe key demographics and treatment features in AF patients visiting cardiologists in various countries in Asia-Pacific.
• To establish correlation between control of AF and clinical outcomes.
• To establish correlation between treatment strategies and AF control.

Enrollment: 2,674 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient presenting with either:

  • History of atrial fibrillation diagnosed < 1 year by standard Electro-Cardiogram (ECG) or by ECG-Holter monitoring (treated or not or whatever rhythm at inclusion).
  • New atrial fibrillation diagnosed by standard ECG or by ECG-Holter monitoring at inclusion visit.

• Patient eligible for a pharmacological treatment of AF (by rhythm or rate control agent).

Exclusion criteria

• AF due to transient cause (thyrotoxicosis, alcohol intoxication, acute phase of myocardial infarction, pericarditis, myocarditis, electrocution, pulmonary embolism or other pulmonary disease, hydroelectrolytic disorder, metabolic disorder, etc.).
• Post cardiac surgery AF (≤3 months).
• Mentally disabled patients unable to understand or sign the written informed consent.
• Patients unable to comply with follow-up visits.
• Patients with pacemaker, Implantable Cardioverter Defibrillator (ICD).
• Patients scheduled for pulmonary vein ablation, AV node/His bundle ablation, or pacemaker implantation.
• Patient included in any clinical trial in the previous 3 months.
• Pregnant or breastfeeding women.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.